Merck – Bayer’s Heart Failure Treatment, Verquvo Scores European Nod
The European Commission (EC) has approved Merck & Co Inc’s (NYSE:MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo (2.5 mg,…
Bayer’s Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes
The FDA on Friday approved Bayer AG’s (OTC:BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid…
Why Did Novocure Shares Plunge Today?
Novocure Ltd (NASDAQ:NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer…
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer
Exelixis Inc (NASDAQ:EXEL) and Ipsen (OTC:IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (Cabometyx) in combination with Roche…
Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals
Bayer AG (OTC:BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the…
Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters
A U.S. judge rejected Bayer AG’s (OTC:BAYRY) plan to try and limit the cost of future class action claims that…